Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Net Cash Flow (2020 - 2025)

Historic Net Cash Flow for LifeStance Health (LFST) over the last 6 years, with Q3 2025 value amounting to $15.0 million.

  • LifeStance Health's Net Cash Flow fell 429.5% to $15.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $101.3 million, marking a year-over-year increase of 6878.52%. This contributed to the annual value of $75.7 million for FY2024, which is 35421.02% up from last year.
  • As of Q3 2025, LifeStance Health's Net Cash Flow stood at $15.0 million, which was down 429.5% from $54.6 million recorded in Q2 2025.
  • LifeStance Health's Net Cash Flow's 5-year high stood at $54.6 million during Q2 2025, with a 5-year trough of -$64.1 million in Q4 2021.
  • Its 5-year average for Net Cash Flow is $732058.8, with a median of $11.3 million in 2023.
  • In the last 5 years, LifeStance Health's Net Cash Flow tumbled by 48267.72% in 2023 and then skyrocketed by 23169.48% in 2024.
  • Quarter analysis of 5 years shows LifeStance Health's Net Cash Flow stood at -$64.1 million in 2021, then surged by 128.53% to $18.3 million in 2022, then surged by 98.08% to $36.2 million in 2023, then surged by 43.45% to $52.0 million in 2024, then crashed by 71.18% to $15.0 million in 2025.
  • Its Net Cash Flow was $15.0 million in Q3 2025, compared to $54.6 million in Q2 2025 and -$20.2 million in Q1 2025.